NDC11 00713088301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00713-0883-01 | 00713-0883 |
| 00713-0883-1 | 00713-0883 |
| 00713-883-01 | 00713-883 |
| 0713-0883-01 | 0713-0883 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Evoxac | CEVIMELINE HYDROCHLORIDE | Cosette Pharmaceuticals, Inc. | dac32a9b-05b8-42c2-9a29-d885a9279456 | 2022-09-07 | Warnings, Adverse reactions | 0713-0883-01 0713-0883 00713088301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.